Triage performance of DNA methylation for women with high-risk human papillomavirus infection
PAX1 m /JAM3 m testing is highly specific for detecting CIN3+. As a triage biomarker, it is superior to HPV 16/18 genotyping and LBC testing for women with hrHPV infection.
Authors
- Xiaoping Xiao (ORCID: https://orcid.org/0000-0001-5021-9906)
- Yu‐Ligh Liou (ORCID: https://orcid.org/0000-0003-3994-6250)
- Jinghe Lang
- Xitong Jin (ORCID: https://orcid.org/0000-0002-8561-046X)
- Linghua Kong (ORCID: https://orcid.org/0000-0002-0270-0540)
- Yan You (ORCID: https://orcid.org/0000-0002-2703-5794)
- Huanwen Wu (ORCID: https://orcid.org/0000-0002-3996-3176)
- Pei Liu (ORCID: https://orcid.org/0000-0003-0069-1668)
- Lei Li (ORCID: https://orcid.org/0000-0001-8723-3461)
Institutions
- Chinese Academy of Medical Sciences & Peking Union Medical College (CN)
- Peking Union Medical College Hospital (CN)
- National Clinical Research Center for Digestive Diseases (CN)
- First Affiliated Hospital of Guangdong Pharmaceutical University (CN)
- National Clinical Research (US)
- OriginWater (China) (CN)
Publication Details
- Journal
- The Oncologist
- Published
- 2024-11-27
- DOI
- https://doi.org/10.1093/oncolo/oyae324
- Citations
- 5
- Primary Topic
- Cervical Cancer and HPV Research
- Type
- article
- Field-Weighted Citation Impact
- 1.93
Funders
- China Postdoctoral Science Foundation
- Peking Union Medical College Hospital
- Chinese Society of Clinical Oncology
- Peking Union Medical College